Sept 5 (Reuters) - Some U.S. stocks on the move on Thursday:
Stocks opened little changed on Thursday as investors were reluctant to make big bets following a strong start to the month and ahead of data that could alter expectations for changes to monetary policy.
The Dow Jones industrial average rose 4.86 points or 0.03 percent, to 14,935.73, the S&P 500 gained 1.7 points or 0.1 percent, to 1,654.78 and the Nasdaq Composite added 4.136 points or 0.11 percent, to 3,653.178.
** BAZAARVOICE INC, $9.86, down 12 pct (9:43 a.m. ET)
The consumer review aggregator forecast second-quarter revenue largely below Wall Street estimates after posting first-quarter revenue that was marginally ahead of expectations.
** GROUPON INC, $11.03, up 7 pct (9:44 a.m. ET)
Brokerage Morgan Stanley upgraded the daily deals company's stock to "overweight" from "equalweight", according to Streetinsider.com. Analyst Scott Devitt also raised his price target on the stock to $14 from $11, citing the recent turnaround in North America with the introduction of deal bank, and strength in mobile. (link.reuters.com/vej82v)
Over half of Groupon’s local transactions in North America came from “deal bank” of longer-term merchant offers. In March more than 60 percent of the contracts Groupon signed with merchants were for longer-term deals, the company said in May.
The company also said about 45 percent of North American transactions came from mobile devices in March, up from about 20 percent two years ago.
** CONN‘S INC, $60.59, down 11 pct (9:32 a.m. ET)
The specialty retailer of items such as home appliances and consumer electronics reported second-quarter profit that missed analysts’ estimates, hurt by a higher provision for bad debts in its credit business due to increased delinquency.
** NPS PHARMACEUTICALS INC, $27.71, up 5 pct (09:31 a.m. ET)
Leerink Swann said it has an “increased bullishness” about the commercial potential of the company’s experimental hypoparathyroidism treatment Natpara and raised its price target on the stock to $35 from $25.
** EXA CORP, $13.78, down 5 pct (9:45 a.m. ET)
The software maker reported lower-than-expected results for the second quarter and forecast third-quarter revenue below analysts’ expectations as customers of its truck and off-highway products delayed closing deals.
** CATALYST PHARMACEUTICAL PARTNERS INC, $1.86, down 4 pct (9:45 a.m. ET)
The specialty pharmaceutical company said it would sell 8.8 million shares of its common stock at $1.72 per share in a registered direct public offering, an 11 percent discount to the stock’s closing price.
** JOS. A. BANK CLOTHIERS INC, $42.23, up 6 pct (9:46 a.m. ET)
The men’s apparel and accessories retailer reported second-quarter sales slightly above analysts’ estimates and said its third quarter is off to a good start as sales and comparable store sales rose in August.
** TITAN MACHINERY INC, $16.52, down 4 pct (9:46 a.m. ET)
The farm equipment retailer reported second-quarter earnings below analysts’ estimates and cut its forecast for the full year as it expects demand to remain weak, given lower corn prices and a reduced harvest.
** LOUISIANA-PACIFIC CORP, $16.86, up 10 pct (9:47 a.m. ET)
The building products maker said it would buy Canadian peer Ainsworth Lumber Co Ltd for about $1.1 billion, including debt, to expand in Asia and other international markets.
** GREIF INC, $53.00, down 5 pct (9:47 a.m. ET)
The packaging products maker reported third-quarter revenue below analysts’ estimates and said it expects its rigid industrial packaging business to remain weak.
** ENVIVIO INC, $3.50, up 25 pct (9:48 a.m. ET)
The video delivery company reported second-quarter results above expectations, driven by large orders from two tier 1 North American cable customers, one of which was a new customer.
The company got 30.2 percent of its revenue in the quarter from the new tier 1 U.S. cable customer.
Sweden’s SKF, the world’s biggest bearings maker, said on Thursday it had agreed to buy U.S.-based Kaydon Corporation in an all-cash $1.25 billion deal. SKF, which competes with U.S. group Timken TKR.N and Germany’s Schaeffler AG, said the deal included $95 million of net debt and would be paid with cash on hand, boosting the group’s earnings in the first year after the transaction.
** SMITHFIELD FOODS INC, $35.52, up 23 pct (9:49 a.m. ET)
The U.S. government is unlikely to block Chinese meat company Shuanghui International’s $4.7 billion deal to buy Smithfield Foods on national security grounds, one person familiar with the matter told Reuters.
** POZEN INC, $5.80, up 10 pct (9:51 a.m. ET)
Under an agreement worth up to $35 million, the U.S. drugmaker granted France-based Sanofi a license to exclusively market two tablets it is developing to prevent cardiovascular disease in patients at risk for aspirin-associated gastric ulcers. A marketing application for the drug was accepted for approval by U.S. health regulators in May 2013, Pozen said late Wednesday.
** CHELSEA THERAPEUTICS INC, $3.18, up 4 pct (9:52 a.m. ET)
The U.S. Food and Drug Administration acknowledged receipt of Chelsea’s marketing application for its hypotension drug Northera and scheduled Feb. 14, 2014, as the review date for the product, the drugmaker said on Wednesday.
Compiled by Varun Aggarwal